Samsung Bioepis and Teva Expand Strategic Partnership to Advance Up to Six Potential Biosimilar CandidatesBusiness Wire • 10/01/26
TAPI (Technology & API Services) Names Serge Rogasik CEO to lead next chapter of growth and competitivenessGlobeNewsWire • 09/30/26
Teva Continues Biosimilar Momentum with U.S. FDA Approval of DEGEVMA™ (denosumab-adet), a Biosimilar to Xgeva® (denosumab)GlobeNewsWire • 09/28/26
Teva to Host Conference Call to Discuss Third Quarter 2026 Financial Results on November 3, 2026 at 8 a.m. ETGlobeNewsWire • 09/23/26
Teva Pharmaceutical Industries Limited (TEVA) Presents at Bank of America Global Healthcare Conference 2026 TranscriptSeeking Alpha • 09/23/26
Teva Pharmaceutical Industries Limited (TEVA) Presents at U.S. All Stars Conference TranscriptSeeking Alpha • 09/22/26
Medincell's Partner Teva Presented New Data on Investigational Olanzapine LAI and UZEDY® at Psych Congress 2026Business Wire • 09/21/26
New Teva Study Identifies the Attributes that Healthcare Providers Prioritize when Selecting a Treatment for Tardive Dyskinesia in Older PatientsGlobeNewsWire • 09/18/26
Teva Highlights New Real-World Data Showing UZEDY® (risperidone) Outperforms Other Long-Acting Injectables in Keeping Schizophrenia Patients on Treatment, While Reducing Emergency Care and Healthcare CostsGlobeNewsWire • 09/18/26
Teva Announces New Olanzapine LAI (TEV-'749) Post Hoc Data Highlighting High Rates of Stabilization and Long-Term Efficacy as Once-Monthly Subcutaneous Injectable for the Treatment of Schizophrenia in AdultsGlobeNewsWire • 09/18/26
Teva Pharmaceutical Industries Limited (TEVA) Presents at Morgan Stanley 24th Annual Global Healthcare Conference TranscriptSeeking Alpha • 09/14/26
Teva Pharmaceuticals Sees Pivot to Growth Accelerating on Branded Drugs, BiosimilarsMarketBeat • 09/14/26
Teva Begins Trading Ordinary Shares Directly on the NYSE, Marking a Milestone in its Pivot to Growth StrategyGlobeNewsWire • 09/14/26
S&P Global Ratings Upgrades Teva to BBB-, Marking Third Credit Rating Upgrade in Recent Months and Reflecting Strong Execution and Financial DisciplineGlobeNewsWire • 09/04/26